Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: an immunohistochemical descriptive study.

Abdel Fattah NS, Ahmed NS.

Exp Parasitol. 2012 Jan;130(1):58-62. doi: 10.1016/j.exppara.2011.09.014. Epub 2011 Oct 12.

PMID:
22019417
2.

Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis.

Andrade ZA, Baptista AP, Santana TS.

Mem Inst Oswaldo Cruz. 2006 Sep;101 Suppl 1:267-72.

3.

Angiogenesis and schistosomiasis.

Andrade ZA, Santana TS.

Mem Inst Oswaldo Cruz. 2010 Jul;105(4):436-9.

4.

Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.

el-Badrawy NM, Hassanein HI, Botros SS, Nagy FM, Abdallah NM, Herbage D.

Exp Mol Pathol. 1988 Oct;49(2):151-60.

PMID:
3139442
5.

Praziquantel efficacy in mice infected with PZQ non-susceptible S. mansoni isolate treated with artemether: parasitological, biochemical and immunohistochemical assessment.

Botros SS, Hammam O, Mahmoud M, Bergquist R.

APMIS. 2010 Sep 1;118(9):692-702. doi: 10.1111/j.1600-0463.2010.02645.x.

PMID:
20718722
6.

The host's genetic background determines the extent of angiogenesis induced by schistosome egg antigens.

Van de Vijver KK, Colpaert CG, Jacobs W, Kuypers K, Hokke CH, Deelder AM, Van Marck EA.

Acta Trop. 2006 Oct;99(2-3):243-51. Epub 2006 Sep 27.

PMID:
17007805
7.
8.

Thalidomide failed to inhibit angiogenesis and fibrosis in hepatic schistosomiasis of the mouse.

Lima CB, Iglesias KB, Andrade ZA.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):883-5. Epub 2007 Dec 11.

9.

Reversal of hepatic fibrosis after praziquantel therapy of murine schistosomiasis.

Morcos SH, Khayyal MT, Mansour MM, Saleh S, Ishak EA, Girgis NI, Dunn MA.

Am J Trop Med Hyg. 1985 Mar;34(2):314-21.

PMID:
3985273
10.

The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice.

Mahmoud MR, El-Abhar HS, Saleh S.

J Ethnopharmacol. 2002 Jan;79(1):1-11.

PMID:
11744288
11.

Effect of octreotide on the pathology of hepatic schistosomiasis.

Mansy SS, Yehia HA, Hassan MM, Hassan EA, Youssef MM, Hadi AA, Mackenzie CD.

Arzneimittelforschung. 1998 Aug;48(8):855-61.

PMID:
9748716
12.

Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.

Chaiworaporn R, Maneerat Y, Rojekittikhun W, Ramasoota P, Janecharut T, Matsuda H, Kitikoon V.

Southeast Asian J Trop Med Public Health. 2005 Jul;36(4):846-52.

PMID:
16295535
13.

Angiogenesis and schistosomal granuloma formation.

Baptista AP, Andrade ZA.

Mem Inst Oswaldo Cruz. 2005 Apr;100(2):183-5.

14.

Hepatic and intestinal schistosomiasis after orthotopic liver transplant.

Hoare M, Gelson WT, Davies SE, Curran M, Alexander GJ.

Liver Transpl. 2005 Dec;11(12):1603-7.

15.
16.

Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.

Helmy MM, Mahmoud SS, Fahmy ZH.

Exp Parasitol. 2009 Aug;122(4):310-7. doi: 10.1016/j.exppara.2009.04.006. Epub 2009 Apr 21.

PMID:
19389399
18.

Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.

Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ.

J Helminthol. 2002 Dec;76(4):327-33.

PMID:
12498638
19.

Peri-portal fibrosis of the liver due to natural or experimental infection with Schistosoma mansoni occurs in the Kenyan baboon.

Njenga MN, Farah IO, Muchemi GK, Nyindo M.

Ann Trop Med Parasitol. 1998 Mar;92(2):187-93.

PMID:
9625915
20.

Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.

Botros SS, Doughty BL, Shaker ZA, Akl MM, Sharmy R, Diab TM, Hassanein HI.

Int J Immunopharmacol. 1996 Dec;18(12):707-18.

PMID:
9172014

Supplemental Content

Support Center